To mark International Women’s Day (Sunday 8 March), the Cambridge Festival (16 March–2 April) is spotlighting the outstanding achievements of women across a wide range of disciplines.
Ahead of our key-note talk on the future of breast cancer, we spoke with members of the Radiotherapy Research Patient and Public Involvement and Engagement (PPIE) Group, who work alongside researchers and clinicians in Cambridge. Here they reflect on their role, their experiences, and why involving people with lived experience of cancer is essential to improving radiotherapy for future patients.
Shades of Survival, a powerful documentary film featuring Cambridge researchers, highlights global inequities in breast cancer care for Black women. It will have its world premiere at the Cambridge Film Festival later this month.
Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.
Many people with breast cancer ‘systematically left behind’, say researchers in Lancet Commission led by Professor Charlotte Coles.
As the NHS celebrates its 75th anniversary, we look at how the close relationship between the University and the hospitals on its doorstep is driving major improvements in how we care for patients.
Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by University of Cambridge and The Institute of Cancer Research, London.
Seven Cambridge University researchers are among the 59 biomedical and health researchers elected to the Academy of Medical Sciences Fellowship.
Cambridge researchers are jointly leading the first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer.
© 2026 University of Cambridge